HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): Oliver Bernecker Ernst Wolner Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trescher, K. Articles by Podesser, B. K. Search for Related Content PubMed PubMed Citation Articles by Trescher, K. Articles by Podesser, B. K. Related Collections Cardiac - other Myocardial infarction

Eur J Cardiothorac Surg 2004;26:960-967
© 2004 Elsevier Science NL

Adenovirus-mediated overexpression of inhibitor kappa B-alpha attenuates postinfarct remodeling in the rat heart

^a Ludwig Boltzmann Institute for Cardiosurgical Research, Medical University of Vienna, Vienna, Austria
^b Department of Internal Medicine II, Medical University of Vienna, Vienna, Austria
^c Department of Pathology, Medical University of Vienna, Vienna, Austria
^d Department of Vascular Biology and Thrombosis Research, Medical University of Vienna, Vienna, Austria
^e Department of Cardiothoracic Surgery, Medical University of Vienna, Vienna, Austria

Received 3 November 2003; received in revised form 14 July 2004; accepted 16 July 2004.

^* Corresponding authors. Address: Ludwig Boltzmann Institute for Cardiosurgical Research, c/o Institute of Biomedical Research, Medical University of Vienna, AKH-Wein, Währinger Gürtel 18-20, 1090 Vienna, Austria. Tel.: +43-1-40400-5221; fax: +43-1-40400-5229. (E-mail: b.k.podesser{at}cardiovascular-research.at).

Objective: The transcription factor nuclear factor kappa B (NF-kB) plays an important role in the inflammatory response following myocardial infarction. We hypothesized that NF-kB-blockade in an animal model of acute ischemia reduces the inflammatory response and therefore attenuates ventricular remodeling. Methods: Myocardial infarcts (MI) were produced in male Sprague–Dawley rats by ligation of the LAD and followed by adenovirus-mediated intramyocardial delivery of inhibitor kappa B-gene (n=10), the physiological inhibitor of the transcription factor nuclear factor kappa B, respectively, of a ß-gal reporter-gene (n=11). Sham-operated animals (n=10) received neither ligation nor gene transfer. Five days after MI IkB-expression levels were determined by western blotting. Seven weeks after MI in vivo cardiac function was evaluated by transthoracic echocardiography. Based on left ventricular endsystolic and enddiastolic diameters ejection fraction and fractional shortening were calculated. Only animals with MI involving more than 30% of the left ventricle were included. Data are given as mean±SD. Results: In IkB-transfected hearts IkB-levels were six-fold higher (P<0.05) than in ß-gal transfected hearts. Concerning in vivo hemodynamics IkB-treated hearts showed reduced systolic and diastolic left ventricular dimensions compared to the ß-gal MI-group (systolic 48±4 vs. 66±3mm; diastolic 67±5 vs. 84±6mm; P<0.01). Consequently fractional shortening (27.8±1.5 vs. 20.4±4.0%; P<0.01) and ejection fraction (63.4±3.6 vs. 49.1±8.3%; P<0.05) were preserved in IkB hearts compared to ß-gal MI-hearts. Conclusion: It can be concluded that overexpression of IkB leads to an improved cardiac function thereby attenuating postinfarct remodeling.

This article has been cited by other articles:

				K. Trescher, M. Bauer, W. Dietl, S. Hallstrom, N. Wick, M. Wolfsberger, R. Ullrich, G. Jurgens, E. Wolner, and B. K. Podesser Improved myocardial protection in the failing heart by selective endothelin-A receptor blockade J. Thorac. Cardiovasc. Surg., April 1, 2009; 137(4): 1005 - 1011. [Abstract] [Full Text] [PDF]

				J. Davis, M. V. Westfall, D. Townsend, M. Blankinship, T. J. Herron, G. Guerrero-Serna, W. Wang, E. Devaney, and J. M. Metzger Designing Heart Performance by Gene Transfer Physiol Rev, October 1, 2008; 88(4): 1567 - 1651. [Abstract] [Full Text] [PDF]

				Y. Onai, J.-i. Suzuki, Y. Maejima, G. Haraguchi, S. Muto, A. Itai, and M. Isobe Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction Am J Physiol Heart Circ Physiol, January 1, 2007; 292(1): H530 - H538. [Abstract] [Full Text] [PDF]

				G. Csanyi, M. Bauer, W. Dietl, M. Lomnicka, T. Stepuro, B. K. Podesser, and S. Chlopicki Functional alterations in NO, PGI2 and EDHF pathways in the aortic endothelium after myocardial infarction in rats Eur J Heart Fail, December 1, 2006; 8(8): 769 - 776. [Abstract] [Full Text] [PDF]

				K. Trescher, O. Bernecker, B. Fellner, M. Gyongyosi, R. Schafer, S. Aharinejad, R. DeMartin, E. Wolner, and B. K. Podesser Inflammation and postinfarct remodeling: Overexpression of I{kappa}B prevents ventricular dilation via increasing TIMP levels Cardiovasc Res, February 15, 2006; 69(3): 746 - 754. [Abstract] [Full Text] [PDF]

				M. Brown, M. McGuinness, T. Wright, X. Ren, Y. Wang, G. P. Boivin, H. Hahn, A. M. Feldman, and W. K. Jones Cardiac-specific blockade of NF-{kappa}B in cardiac pathophysiology: differences between acute and chronic stimuli in vivo Am J Physiol Heart Circ Physiol, July 1, 2005; 289(1): H466 - H476. [Abstract] [Full Text] [PDF]